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Abstract
Background: Electrophysiological studies have become an established practice in the evaluation and treatment of
arrhythmias. Symptomatic pulmonary embolism as a result of deep vein thrombosis arising from multiple venous
sheath femoral vein catheterization is an uncommon complication associated with it. We report the case of a
33-year-old woman who developed pulmonary embolism after an electrophysiological study, which was
successfully treated at a cardiac hospital in Bangladesh.
Case presentation: A 33-year-old Bangladeshi woman with hypertension and diabetes had initially presented
with recurrent episodes of paroxysmal atrial fibrillation that manifested as palpitations for 2 years. Her atrial
fibrillation was drug-refractory and could not be attributed to a treatable etiology. She had undergone an
electrophysiological study at a different hospital, where right femoral venous catheterization was performed
followed by the insertion of three venous sheaths. However, tachyarrhythmia could not be induced and a
procedure to isolate the pulmonary vein was postponed because all the veins could not be isolated. Forty-eight hours
later, she presented to our hospital with shortness of breath, chest heaviness, palpitations, and recurrent
episodes of syncope.
She had normal coronary arteries and no other risk factors for venous thromboembolism. She was hemodynamically
stable on examination. There was echocardiographic evidence of pulmonary hypertension and right ventricular
dilatation and dysfunction. A computed tomography pulmonary angiogram confirmed pulmonary embolus in the
descending branch of her left pulmonary artery, extending up to the segmental arteries.
Subsequently, a duplex ultrasound confirmed acute deep vein thrombosis affecting her right ilio-femoral
segment. She was successfully managed with subcutaneous enoxaparin and oral warfarin (target international
normalized ratio 2.5–3).
Conclusions: Pulmonary embolism is a rare but serious complication that may occur in patients who undergo
electrophysiological studies. Multiple venous sheaths inserted into the femoral vein and catheter-induced endothelial
injury, further compounded by prolonged procedural time, may be responsible for the increased
thrombogenicity leading to deep vein thrombosis and subsequent pulmonary embolism. An adequate
observation time after the procedure and clinical alertness are necessary for rapid diagnosis and treatment.
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Background
Over the years, clinical electrophysiological studies (EPS)
have become a recognized component of the diagnostic
evaluation of and therapeutic strategy for patients with
different cardiac arrhythmias [1–3]. Catheter ablation is
a class IA recommendation for the treatment of paroxysmal
and symptomatic atrial fibrillation (AF) that are refractory
or intolerant to at least one class 1 or 3 antiarrhythmic
medication. Pulmonary vein isolation (PVI) is the corner-
stone of the strategy, although the procedure itself can be
challenging: it requires considerable procedural time and
operator expertise, and is limited by the infrequency with
which AF initiation can be reproducibly triggered [4].
Depending on the type of procedure, age of the patient,
and comorbidities, major complications occur in approxi-
mately 1.1 % of patients undergoing EPS, with a signifi-
cantly higher complication rate of 3.1 % among those
undergoing radiofrequency catheter ablation (RFCA) [5].
The procedure-related complications arising from clinical
cardiac EPS include pulmonary embolism (PE), cardiac
perforation, arterial injury, thrombophlebitis, systemic ar-
terial embolism, and sometimes death [6]. EPS involve the
percutaneous introduction of one or multiple catheters to
record the electrical activity of the heart or to pace its dif-
ferent cavities. The introduction and manipulation of these
catheters in arteries, veins, or cardiac cavities may activate
the coagulation cascade, risking thromboembolism, such as
deep vein thrombosis (DVT). Furthermore, withdrawal of
catheters induces hemorrhage, usually limited by the com-
pression of the site of venous or arterial puncture, leading
to venous stasis and a further thrombogenic state [7].
Symptomatic PE following EPS is relatively uncommon,
with a complication rate between 0 and 1.7 % [6, 8].
Despite its low incidence, it is a serious complication, with
a mortality of greater than 15 % in the first 3 months
following the diagnosis [9, 10]. Prompt diagnosis and
management of venous thromboembolism (VTE) and
subsequent PE can result in a good outcome [11]. A better
understanding of the risk factors for PE and the proactive
administration of thromboprophylaxis in high-risk pa-
tients may help minimize the risk of this complication [9].
We report the case of a woman who presented with DVT
with PE, occurring as a complication of EPS. Our patient
was successfully treated with subcutaneous enoxaparin
and subsequent warfarin.
Case presentation
A 33-year-old Bangladeshi woman with hypertension and
diabetes had initially presented to a different hospital with
intermittent episodes of palpitations for 2 years, with
documented electrocardiographic (ECG) evidence of AF
during the episodes. She had previously been on oral pro-
pafenone, amiodarone, and metoprolol, at separate times,
but continued to experience paroxysmal AF.
She had a 2-year history of hypertension that was well
controlled with metoprolol 50 mg twice daily and ramipril
5 mg once daily. She had type 2 diabetes mellitus, diag-
nosed 3 years previously, that was well controlled with
metformin 500 mg twice daily. There was no evidence of
diabetic nephropathy or microalbuminuria. Furthermore,
other etiologies of AF, such as thyrotoxicosis, were excluded
by her thyroid profile, which comprised normal levels of
TSH, free triiodothyronine, and free thyroxine. Ischemic
heart disease was excluded by a CT coronary angiogram,
which revealed normal epicardial coronary arteries.
Given the indication of drug-refractory AF, our
patient had undergone EPS at a different hospital
from which she had been discharged 24 hours after
the procedure. The EPS has comprised right femoral
venous catheterization followed by the insertion of
three venous sheaths into her femoral vein.
Because an inducible arrhythmia could not be repro-
duced, her pulmonary vein (PV) potentials were mapped
and complete PV isolation was planned. But, because there
was difficulty in isolating some of the PVs along with an ex-
tended procedural time, the procedure was abandoned. A
plan was made to identify all PVs more specifically using
other imaging techniques such as magnetic resonance
imaging (MRI), prior to attempting the procedure again.
She presented to our hospital 48 hours after the EPS with
shortness of breath and chest heaviness, associated with
palpitations and recurrent episodes of syncope. When quer-
ied, she confirmed that these symptoms were not like those
she had previously experienced during her paroxysms of
AF, and reiterated that they only developed after the EPS.
She had no prior history of thromboembolic events,
long flights, prolonged immobilization, or oral contracep-
tive use, and she denied any family history of thrombo-
philia. There was no evidence of either hypertensive or
diabetic nephropathy. A urine dipstick test was negative
for protein. A thrombophilia work-up revealed normal
levels for protein C and S, antinuclear antibody, and antic-
ardiolipin antibody, thus eliminating other causes of
hypercoagulability as possible etiologies of thrombosis.
On examination, she was hemodynamically stable and
heart and lung auscultation was unremarkable. There
was no unilateral leg swelling. An ECG showed T inver-
sions in leads III, aVF, and V1–4. It also revealed mild
tricuspid regurgitation and a pulmonary artery systolic
pressure (PASP) of 50 mmHg. Her right ventricle (RV)
was dilated, with diameters measuring 38 mm at the
basal level and 40 mm at mid-level, with a longitudinal
measurement of 90 mm on the apical 4 chamber view.
Tricuspid annular plane systolic excursion (TAPSE) was
measured at 12 mm. Her left atrium (LA) was of normal
size and measured 33 mm. Qualitative assessment re-
vealed that right atrium was larger than her LA. There
was no evidence of left ventricular (LV) hypertrophy. Her
Nasrin et al. Journal of Medical Case Reports  (2016) 10:89 Page 2 of 6
LV ejection fraction (EF) was 65 % and there were no
regional wall motion abnormalities of her LV. There was
no evidence of thrombus in any of the cardiac chambers.
A CT coronary and pulmonary angiogram revealed
normal coronaries with filling defects in the descending
branch of her left pulmonary artery extending into the
segmental arteries, suggesting thrombus (Fig. 1).
Subsequently, a duplex ultrasound study of her lower
limb venous system showed absent blood flow in her
right external and common femoral veins, confirming
acute DVT affecting her right ilio-femoral segment with-
out signs of recanalization (Fig. 2).
Given the sequence of events and their temporal relation-
ship with the EPS, and in the absence of other risk factors
for DVT, it was established that the acute DVT occurred as
a consequence of the femoral vein catheterization and mul-
tiple venous sheaths inserted for EPS, subsequently leading
to PE. She was treated with subcutaneous enoxaparin 60
mg twice daily for 5 days along with the administration of
oral warfarin. She continued taking the warfarin for 6
months, with a target therapeutic international normalized
ratio of 2.5–3. She was asymptomatic at follow-up at
six months, and, due to the resolution of the DVT, oral
anticoagulation was discontinued.
Discussion
Clinical cardiac EPS with or without RFCA is an import-
ant component of the diagnostic and therapeutic work-up
of serious arrhythmias. RFCA following EPS has become
the treatment of choice for a wide variety of arrhythmias,
including AF, atrial flutter, and supraventricular and
ventricular tachycardias [7].
Ablation strategies that target the PVs and/or PV an-
trum are the cornerstone for most AF ablation procedures
[4]. However, unlike other supraventricular arrhythmias,
the provocation of PV ectopy is a challenge. Direct cath-
eter ablation can be limited by a paucity of spontaneous
or inducible arrhythmias during the procedure and the in-
frequency with which AF initiation can be reproducibly
triggered, as was the case in our patient [12]. Around 3 %
of paroxysmal AF have no inducible ectopy-initiating AF
[13]. This is further compounded by the difficulty of
precise mapping within the venous structures [4].
The identification of arrhythmogenic PVs can be time-
consuming, because focal activity can be difficult to
observe or induce during the procedure [12]. Patients
with paroxysmal AF usually have multiple PV foci in
multiple veins, and many of these foci originate distally
(that is, 2–4 cm) in those veins [12]. Thus, the goal of
PV isolation is to produce complete electrical isolation
of all PVs in the hope of abolishing the initiating triggers
[13], because PVI of only arrhythmogenic veins has been
shown to have limited success rate [12].
However, significant variability in PV anatomy and
morphology exists, leading to technical difficulties. Diffi-
culty in catheter navigation may represent inaccuracy in the
electro-anatomic map or result from patient movement
during the procedure. Cannulation of the right inferior PV
in particular can be challenging, requiring a prolongation of
total procedural time. Also, the more proximal PV ablation
approach requires correct identification of the ostia and
PV-LA junction to prevent pulmonary stenosis [12, 13].
Thus, recognition of the individual patient’s anatomy is
critical to success. In our case, a further attempt at PVI was
planned after pre-procedural imaging, and after we had the
exact location of the pulmonary ostia.
PE complicated by EPS is rare, with previous studies
demonstrating an overall incidence of 0–0.25 % [14–17].
PE following EPS can be either benign and asympto-
matic, or symptomatic with life-threatening consequences
requiring urgent intervention [8, 11, 14, 15]. There are
various risk factors associated with VTE, including obesity,
immobilization, hospitalization, malignancy, long flights,
the use of the combined oral contraceptive pill, and
central venous catheterization [18]. Having ruled out the
other risk factors associated with VTE in our patient, her
recent femoral vein catheterization for EPS remained
as the evident cause for the development of DVT and
PE. Furthermore, the prolonged procedural time with
in situ venous sheaths could have been an additional
factor contributing to the development of venous
thrombosis.
PE after EPS is frequently underestimated [19], with
some authors even advocating same day discharge after
EPS [16]. Primm et al. [19] reported that 12 % of patients
had new perfusion defects detected by ventilation-
perfusion lung scans 1 day after routine right-heart
catheterization, suggesting that PE may be more common
than previously appreciated.
Fig. 1 CT pulmonary angiography showing thrombus. CT pulmonary
angiogram shows filling defects in descending branch of left pulmonary
artery (arrow heads) extending up to segmental arteries, suggesting
thrombus.
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The source for PE is often attributed to a DVT aris-
ing from the punctured femoral vein [14]. Venous
catheterization and the use of multiple venous sheaths
inserted into a single femoral vein is an essential
component of most EPS and RFCA [9, 14]. Multiple intra-
cardiac catheters are often necessary for EPS and RFCA
therapy, and this almost always requires multiple venous
sheath placements in a single femoral vein [20].
Chen and colleagues [20] reported that such use of
multiple (that is, up to three) femoral sheaths in a single fem-
oral vein during EPS resulted in a high incidence (19.2 %) of
non-occlusive DVT detected by duplex ultrasonography on
the day following the EPS. Although the outcome of non-
occlusiveDVT in the study by Chen et al. [20] was largely be-
nign in most patients, and they concluded that short-term
placement ofmultiple venous sheaths in a single femoral vein
appeared to be safe, they advised close follow-up to avoid
potential vascular complications.
Our patient had three sheaths inserted into her right
femoral vein. She had a relatively long procedure time of
approximately 70 minutes. Following the EPS, she stated
that she had a relatively long duration of hemostasis
(approximately 3.5 hours) with sandbag application. This
may have compressed her femoral vein, leading to venous
stasis. Authors have suggested that both venous stasis and
injury to vascular endothelium caused by multiple ven-
ous sheath placements may be possible mechanisms for
the formation of DVT and subsequent PE [7, 14].
The mechanisms of thromboembolism during EPS and
peri-ablation have been open to much speculation [21]. Al-
though the pathophysiology of thromboembolism may be
multifactorial, it is the fulfillment of Virchow’s triad in the con-
text of an electrophysiological procedure that leads to a pro-
thrombotic or hypercoagulable state resulting inVTE [7, 21].
Davutoglu et al. [22] reported a significant increase in
occult femoral vein thrombosis following the use of
multiple femoral venous sheaths, without using heparin,
in patients undergoing EPS. The incidence of femoral
vein thrombosis was high (62.5 %); however, no patients
showed clinical features of PE. Furthermore, a prophylac-
tic fixed dose of body weight-independent low-molecular-
weight heparin (LMWH) significantly decreased the risk of
femoral thrombosis in these patients (18 %) [22]. They at-
tributed the main risk factors for DVT in EPS to be cath-
eter thrombogenicity, lack of anticoagulation, and occlusion
of the lumen secondary to multiple introducer sheaths. In
cases of ablation, the increased activation of the clotting
system could be an additional factor for thrombosis [22]. In
fact, Chen et al. [5] reported that RFCA presents a signifi-
cantly higher overall complication rate in comparison to
EPS alone (3.1 % versus 1.1 %, respectively, P = 0.00002).
Typically, a PE can develop from 8.5 hours to 14 days after a
EPS procedure [9, 15], thus warranting a minimum period of
observation for complications after procedure. However, Mari-
jon and colleagues [16] suggested that same-day home dis-
charge after 4–6 hours of observation is safe for uncomplicated
RFCA, despite the fact they noted symptomatic delayed PE.
Our patient presented with PE 48 hours after EPS, and
24 hours after discharge. Thus, we believe that a longer
observation period may be needed in some patients, par-
ticularly those who have a longer duration of hemostasis.
Additionally, a duplex ultrasonography of the lower
limbs prior to discharge may be prudent to evaluate the
formation of thrombus at the site of the punctured
femoral veins, especially in those patients being discharged
on the same day.
There is also the alternative issue of the role of anti-
coagulation during and following electrophysiological
Fig. 2 Duplex ultrasound scan of right lower limb showing deep vein thrombosis. Duplex scan shows absent blood flow in the right common
femoral veins (panel a) and right popliteal vein (panel b), indicating deep vein thrombosis
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procedures in preventing VTE after EPS. There is currently
no definitive consensus regarding the use of anticoagulants
either during or after routine EPS, including those involving
catheter ablation [7]. A policy statement by the North
American Society of Pacing and Electrophysiology (NASPE)
suggested the application of heparinization for catheter
manipulation during left-sided RFCA [1].
Evidence from this case and others [11, 14] suggests
that, although rare, VTE and PE are potentially life-
threatening in certain patients after EPS. Based on the
frequency and potential long-term complications of PE,
there is a pressing need for more evidence-based con-
sensus concerning the issues of anticoagulation and the
prevention of VTE during routine EP procedures [11].
Conclusions
Although rare, PE arising from DVT may occur even in
patients undergoing EPS with a short procedure time. A
prolonged procedure time may further increase the risk
of developing DVT. Furthermore, the symptoms of PE
may be easily misinterpreted to be those of the initial
arrhythmia; as such, prompt diagnosis and treatment
requires a high index of suspicion for PE in the case of
new symptoms in post-EPS cases. There is also a close
relationship between EPS and thrombus formation and,
thus, there is a need to balance the risks between
thromboembolism and bleeding. Endothelial injury
resulting from multiple venous sheaths and prolonged
hemostatic mechanisms may be responsible for the
formation of DVT. There are no guidelines on the use of
antithrombotic therapies in the setting (that is, before,
during, and after) of EPS, and an evidence-based con-
sensus is warranted.
Consent
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for publication of this case report and any accompanying
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